| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.45M | 9.35M | 7.83M | 3.78M | 2.08M | 240.20K |
| Gross Profit | 10.37M | 9.27M | 7.74M | 3.65M | 1.89M | 72.15K |
| EBITDA | 5.54M | 4.40M | 3.14M | 841.03K | -1.19M | -3.68M |
| Net Income | 4.14M | 2.59M | 3.04M | 840.18K | -2.83M | -87.57M |
Balance Sheet | ||||||
| Total Assets | 28.55M | 69.76M | 62.59M | 53.11M | 51.67M | 11.93M |
| Cash, Cash Equivalents and Short-Term Investments | 20.33M | 24.23M | 16.93M | 11.37M | 9.12M | 10.84M |
| Total Debt | 205.30K | 256.67K | 191.23K | 235.03K | 229.30K | 333.13K |
| Total Liabilities | 1.99M | 1.65M | 1.01M | 833.21K | 974.57K | 1.05M |
| Stockholders Equity | 26.56M | 68.11M | 61.58M | 52.28M | 50.69M | 10.88M |
Cash Flow | ||||||
| Free Cash Flow | 2.08M | 3.05M | -498.60K | 671.42K | -3.56M | -3.87M |
| Operating Cash Flow | 2.64M | 3.05M | 1.36M | 687.12K | -3.53M | -3.79M |
| Investing Cash Flow | -983.27K | 1.02M | -3.80M | -349.41K | 2.05M | -1.16M |
| Financing Cash Flow | -7.32M | 2.92M | 5.29M | 251.49K | 718.10K | 4.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | C$138.90M | 30.31 | 9.02% | ― | 39.37% | ― | |
69 Neutral | $246.67M | 150.93 | 3.44% | 2.20% | 5.24% | -17.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | C$1.43B | 75.98 | 2.92% | ― | 131.18% | 150.47% | |
47 Neutral | C$742.56M | -29.47 | -81.62% | ― | ― | 18.96% | |
46 Neutral | C$498.93M | -62.16 | ― | ― | ― | 46.54% | |
36 Underperform | C$300.59M | -29.57 | -22.27% | ― | ― | 50.13% |
Orogen Royalties Inc. reported strong financial results for Q3-2025, with net income before tax rising significantly to $1.32 million from $0.25 million in the previous year. The company’s royalty revenue increased by 9% to $2.3 million, despite a decrease in gold equivalent ounces sold. Orogen’s cash flow from operating activities remained robust, and the company maintained a strong working capital position of $21.64 million, allowing it to continue expanding its royalty portfolio. These results underscore the resilience and scalability of Orogen’s business model, positioning it well for future growth and value creation.
Orogen Royalties Inc. has announced the grant of 2,000,000 incentive stock options to its directors, officers, employees, and consultants as part of its Omnibus Equity Incentive Compensation Plan. These stock options, which have a five-year life and an exercise price of $2.20, will vest over three years and are subject to regulatory acceptance by the TSX Venture Exchange. This move reflects Orogen’s commitment to incentivizing its team and aligning their interests with the company’s growth objectives.
Orogen Royalties Inc. has entered into an agreement with Altitude Minerals Ltd., allowing Altitude to acquire the Firenze gold project in Nevada. The deal involves a payment of US$430,000 and a 3% net smelter return royalty, with proceeds from the sale being split between Orogen and its partner, Altius Minerals Corporation. This transaction marks the third royalty generated under Orogen’s alliance with Altius, highlighting the company’s strategic focus on creating value through exploration-stage projects. The Firenze project, with its promising epithermal veins and historical high-grade samples, represents a significant opportunity for future exploration and development.
Orogen Royalties has announced updates on its exploration projects and royalties, highlighting significant drilling activities across various regions including Nevada, British Columbia, Colombia, and Western Kenya. The company has successfully created new royalties through project sales, formed exploration alliances with major industry partners, and is set to host its second annual Project Generator Day to showcase new exploration opportunities. These developments signify a busy year for Orogen, enhancing its market position and offering potential growth opportunities for stakeholders.
Orogen Royalties Inc. has announced that its shares have begun trading on the OTCQB Venture Market under the symbol ‘OGNNF’, marking a significant milestone for the company. This move is expected to enhance liquidity and ease of trading for U.S. shareholders, with future plans to upgrade to the OTCQX market, potentially improving its market positioning and stakeholder engagement.